Cyclophosphamide post transplant

( DrugBank: Cyclophosphamide / KEGG DRUG: Cyclophosphamide, Cyclophosphamide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	4

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03910452 (ClinicalTrials.gov)	October 28, 2019	9/4/2019	Haploidentical Transplantfor People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busu ...	Haploidentical Transplantfor Patients With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Bu ...	Chronic Granulomatous Disease	Drug: Busulfan;Drug: Alemtuzumab;Drug: Cyclophosphamide;Drug: Sirolimus;Radiation: Total Body Irradi ...	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	4 Years	65 Years	All	30	Early Phase 1	United States
2	NCT02629120 (ClinicalTrials.gov)	December 17, 2015	10/12/2015	High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamidefor Patien ...	High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamidefor Patien ...	Chronic Granulomatous Disease Transplant	Drug: Alemtuzumab;Drug: Busulfan;Drug: Sirolimus;Drug: Cyclophosphamide;Radiation: Total Body Irradi ...	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Active, not recruiting	4 Years	65 Years	All	44	Phase 1/Phase 2	United States
3	NCT02282904 (ClinicalTrials.gov)	October 23, 2014	4/11/2014	Haploidentical Transplantfor People With Chronic Granulomatous Disease Using Post Transplant Cycloph ...	Haploidentical Transplantfor Patients With Chronic Granulomatous Disease (CGD) Using Post-Transplant ...	Chronic Granulomatous Disease	Drug: Sirolimus;Biological: Donor peripheral blood stem cells.;Drug: Cyclophosphamide post transplan ...	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Terminated	2 Years	65 Years	All	7	Phase 1/Phase 2	United States
4	NCT00358657 (ClinicalTrials.gov)	May 24, 2006	28/7/2006	Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Tr ...	HLA-Haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and Other N ...	Immunodeficiency Syndrome;Non-Cancer Diagnosis;Severe Aplastic Anemia;Donor	Procedure: Allogeneic Bone Marrow Transplantation;Drug: Cyclophosphamide;Drug: Fludarabine Phosphate ...	Fred Hutchinson Cancer Research Center	National Cancer Institute (NCI);National Heart, Lung, and Blood Institute (NHLBI)	Active, not recruiting	N/A	55 Years	All	14	Phase 2	United States

First Previous1Next Last